Skip to content

About the show

Clinical Data Talks is your go-to podcast for an in-depth look at the evolving world of clinical data capture, management and analysis. Join industry experts and clinical data enthusiasts as we explore the challenges, breakthroughs and innovations shaping the industry. Through fresh perspectives, real-world experiences and forward-thinking discussions, we keep you informed on the latest trends driving the future of clinical trials. Whether you’re a data manager, researcher or passionate about the industry, Clinical Data Talks is your trusted source for insights into the world of clinical data.

Newest episodes

Mastering compliance for combination products with Dr. Khaudeja Bano

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Khaudeja Bano, an industry leader with over 25 years of experience across top pharmaceutical companies and deep expertise in diagnostics, therapeutics, and combination products. Together, they unpack compliance and safety management for combination products and examine how rapid drug-device innovation is moving healthcare directly into patients' hands. With a distinguished background that includes serving on the working group that helped establish 21 CFR Part 4 regulations, Khaudeja shares how the rise of GLP-1 auto-injectors and drug delivery systems is redefining safety data collection. She explains why pharmaceutical sponsors must take holistic ownership of safety, efficacy, and risk management across the entire product – from evaluating human factors and needle protection to feeding real-world usability data back into next-generation device design. Sylvain and Khaudeja discuss the nuances of global regulatory frameworks across the US FDA, EMA, and PMDA, why the controlled environment of clinical trials offers an ideal setting to listen to the patient voice, and how bringing technology partners directly to the regulatory table creates smoother compliance workflows. Tune in to explore how combination products are reshaping safety surveillance, cross-industry collaboration, and the future of patient-centered healthcare.

Growth and the impact on clinical technology with Craig Mooney

31 min Video

Sylvain Berthelot welcomes Craig Mooney to the podcast, Founder and Principal Consultant at IRT Advisors Group. Together, they unpack the trade-offs between standalone point solutions and unified eClinical platforms, exploring how sponsor growth shapes technology choices in clinical trials. With over three decades of clinical trial experience, Craig shares insights from his article Choose Your Hard, explaining why there is no single "right" answer when selecting trial software. He and Sylvain discuss the context that may lead CROs and sponsors to choose specialized point solutions instead of integrated platforms. They also address the hidden operational costs of data reconciliation, why discrepancies like visit dates versus transaction dates are often misunderstood, and how unified platform architectures can eliminate artificial data friction. Tune in to explore how organizational scale, system design, and decision-making structures impact the future of clinical trial technology.

How to make sites want to take part in clinical trials with Vivienne van de Walle

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Vivienne van de Walle, founder of PT&R, an independent clinical site she has successfully led for nearly 30 years. Together, they explore what it takes to make clinical sites truly want to participate in clinical trials and how site-level challenges impact the broader research ecosystem. Drawing on decades of on-the-ground experience, Vivienne highlights the growing operational burden placed on sites and patients due to technology overload and complex study protocols. From the alarming rate of "once-and-done" investigators dropping out after their first trial to Clinical Research Coordinators drowning in standalone systems, she sheds light on how software complexity drives talent out of the industry while taking time away from direct patient care. Sylvain and Vivienne discuss why true patient centricity requires reducing trial burden rather than just collecting more data, how consulting sites early in study design prevents costly protocol deviations, and why rushing trial setup timelines creates severe downstream friction for site operations. Tune in to explore how sponsors can foster better collaboration with sites, simplify digital workflows, and create a more sustainable environment for clinicians, site staff, and patients alike.

Similar podcasts

All episodes

Mastering compliance for combination products with Dr. Khaudeja Bano

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Khaudeja Bano, an industry leader with over 25 years of experience across top pharmaceutical companies and deep expertise in diagnostics, therapeutics, and combination products. Together, they unpack compliance and safety management for combination products and examine how rapid drug-device innovation is moving healthcare directly into patients' hands. With a distinguished background that includes serving on the working group that helped establish 21 CFR Part 4 regulations, Khaudeja shares how the rise of GLP-1 auto-injectors and drug delivery systems is redefining safety data collection. She explains why pharmaceutical sponsors must take holistic ownership of safety, efficacy, and risk management across the entire product – from evaluating human factors and needle protection to feeding real-world usability data back into next-generation device design. Sylvain and Khaudeja discuss the nuances of global regulatory frameworks across the US FDA, EMA, and PMDA, why the controlled environment of clinical trials offers an ideal setting to listen to the patient voice, and how bringing technology partners directly to the regulatory table creates smoother compliance workflows. Tune in to explore how combination products are reshaping safety surveillance, cross-industry collaboration, and the future of patient-centered healthcare.

Growth and the impact on clinical technology with Craig Mooney

31 min Video

Sylvain Berthelot welcomes Craig Mooney to the podcast, Founder and Principal Consultant at IRT Advisors Group. Together, they unpack the trade-offs between standalone point solutions and unified eClinical platforms, exploring how sponsor growth shapes technology choices in clinical trials. With over three decades of clinical trial experience, Craig shares insights from his article Choose Your Hard, explaining why there is no single "right" answer when selecting trial software. He and Sylvain discuss the context that may lead CROs and sponsors to choose specialized point solutions instead of integrated platforms. They also address the hidden operational costs of data reconciliation, why discrepancies like visit dates versus transaction dates are often misunderstood, and how unified platform architectures can eliminate artificial data friction. Tune in to explore how organizational scale, system design, and decision-making structures impact the future of clinical trial technology.

How to make sites want to take part in clinical trials with Vivienne van de Walle

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Vivienne van de Walle, founder of PT&R, an independent clinical site she has successfully led for nearly 30 years. Together, they explore what it takes to make clinical sites truly want to participate in clinical trials and how site-level challenges impact the broader research ecosystem. Drawing on decades of on-the-ground experience, Vivienne highlights the growing operational burden placed on sites and patients due to technology overload and complex study protocols. From the alarming rate of "once-and-done" investigators dropping out after their first trial to Clinical Research Coordinators drowning in standalone systems, she sheds light on how software complexity drives talent out of the industry while taking time away from direct patient care. Sylvain and Vivienne discuss why true patient centricity requires reducing trial burden rather than just collecting more data, how consulting sites early in study design prevents costly protocol deviations, and why rushing trial setup timelines creates severe downstream friction for site operations. Tune in to explore how sponsors can foster better collaboration with sites, simplify digital workflows, and create a more sustainable environment for clinicians, site staff, and patients alike.

Unlocking Latin America's clinical trial potential with Claudia Rodriguez

30 min Video

Sylvain Berthelot welcomes Claudia Rodriguez, CEO of RARAS, a CRO specialized in conducting research across Latin America. Together, they explore the untapped potential of this diverse region and why it is increasingly becoming a strategic priority for global sponsors. With a deep passion for the Latin American market, Claudia dispels common myths about the region’s accessibility and infrastructure. She shares how the landscape is shifting from a traditional focus on Phase 3 "rescue" trials toward early-phase research, driven by geopolitical changes and a growing need for diverse genetic data. Sylvain and Claudia discuss the nuances of different markets, from Chile’s rapid regulatory timelines for medical devices to Brazil’s world-renowned Key Opinion Leaders. They also delve into the unique cultural bond between patients and physicians in the region, which results in remarkably high retention rates. Tune in to our Season 3 finale to discover how strategic planning in Latin America can accelerate regulatory approval, provide a "soft landing" for future product launches, and ensure high-quality data that meets the rigorous standards of the FDA and EMA.

The reality of data fragmentation in clinical trials with Kavita Gaadhe

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Dr. Kavita Gaadhe, a clinical data management lead working at the high-stakes intersection of technology and precision medicine. Together, they explore the increasingly complex reality of managing non-linear data flows in a digitalized landscape. With expertise in navigating the "data mesh" of modern trials, Kavita shares how data managers are no longer just handling EDC systems but are now coordinating a symphony of sources: from multi-omics and imaging to device data and patient-reported outcomes. She explains the friction that occurs when these heterogeneous sources "speak different languages," forcing data teams to spend their days reconciling time points and bridging semantic gaps to meet standardization requirements. Sylvain and Kavita discuss why the industry is currently attempting to bolt 21st-century data onto 20th-century infrastructure, the necessity of viewing data as a strategic asset rather than a byproduct, and why oncology and precision medicine trials demand flexibility from technology first and foremost. Tune in to learn why a holistic mindset shift in vendor selection and a learner’s attitude are essential for surviving—and thriving—in today’s complex clinical data environment.

Clinical data from the patient's perspective with Ella Balasa

30 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Ella Balasa, a patient advocate and leading voice in shaping collaborative approaches to clinical research. Together, they explore the critical importance of embedding the patient voice into every stage of the clinical trial lifecycle to ensure research is truly inclusive and effective. With a deep personal history of navigating the healthcare system as a cystic fibrosis patient, Ella shares the stark realities of trial participation: from the struggle for awareness in rural communities to the heavy physical and logistical burdens of complex procedures. She provides a poignant account of how rigid exclusion criteria can prevent the very patients who need new therapies most from contributing to essential data. Sylvain and Ella discuss why the industry must move beyond traditional endpoints to capture what truly impacts a patient’s quality of life. They also dive into the necessity of optionality, explaining how flexible trial designs can improve enrolment, reduce attrition, and accelerate timelines. Tune in to discover how true partnership between sponsors, regulators, and patient communities can transform trial design from a "one-size-fits-all" model into a meaningful, data-rich collaboration.

The adoption of centralized monitoring by CROs with Jennifer Stewart

33 min Video

Sylvain Berthelot welcomes Jennifer Stewart, Vice President AI and Innovation at Premier Research and an active member of ACRO’s Risk-Based Quality Management (RBQM) working group. Together, they explore the current state of RBQM adoption and what it will take for the industry to fully embrace risk-based approaches in clinical trials. Drawing on insights from ACRO’s annual industry survey, Jennifer shares a candid view of where progress is being made, and where challenges remain. While awareness of RBQM is high, true adoption is still inconsistent, with many organisations implementing elements in isolation rather than as a fully integrated strategy. She explains how this partial adoption limits the overall impact on trial quality and efficiency. Sylvain and Jennifer discuss the key barriers holding the industry back, from persistent reliance on traditional practices like 100% SDV to misconceptions about regulatory expectations. They also highlight the growing role of regulators in encouraging risk-based approaches and why clearer communication and industry confidence are critical to driving change. Tune in to explore how RBQM is evolving, what the latest data tells us about adoption trends, and why shifting mindset – not just technology – is essential to unlocking its full potential.

Innovation in a risk-averse industry with Adam Walker

28 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Adam Walker, a seasoned clinical data management and biometrics consultant. Together, they explore the delicate balance between innovation and the inherently risk-averse nature of the clinical research industry. With extensive experience working for companies of various sizes, Adam has had the opportunity to observe and lead the implementation of innovation. In this episode, he shares his observations and discusses the tension between innovation and established processes, highlighting how legacy workflows can sometimes limit progress. He and Sylvain reflect on the challenge of introducing new technologies into environments where teams are incentivized to avoid risk, and where change can feel disruptive rather than enabling. Adam makes an important point about the importance of mindset and culture. He emphasizes that innovation is not just about technology itself, but about creating an environment where teams feel confident to challenge the status quo, rethink processes, and adopt new ways of working. Tune in to explore how the clinical industry can strike the right balance between stability and innovation, why risk aversion can both protect and hinder progress, and what it will take to unlock meaningful transformation in clinical trials.

The role of standardisation in clinical trials with Chris Decker

33 min Video

Podcast Episode Summary In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Chris Decker, President and CEO of Clinical Data Interchange Standards Consortium (CDISC). Together, they explore the critical role that data standards play in modern clinical research and why greater standardisation is essential to improving how clinical trial data is collected, structured, and shared. Drawing on decades of experience in clinical technology and data solutions, Chris explains how CDISC standards have become a foundation for regulatory submissions and global data interoperability. He highlights what those standards enable to do, but also the work ahead of us to truly achieve the digital transformation the industry needs. A key theme of the conversation is the growing importance of digitizing protocols and designing studies with standards in mind from the beginning. Chris shares how structured protocol models and machine-readable standards could transform study setup, reduce manual work, and enable greater automation across the clinical data lifecycle. Tune in to discover how CDISC standards are shaping the future of clinical trials, why protocol digitization could be a turning point for the industry, and how better data foundations can unlock innovation in clinical research.

Beyond the data: Human stories from clinical trials in Ukraine

29 min Video

In this final episode of season 2, Sylvain Berthelot welcomes Anna Titkova, who shares her first-hand experience of running clinical trials in Ukraine before and during the conflict. In 2022, Anna lived in Ukraine and acted as the country head for Pratia, a research site network. Anna describes how Ukraine, once a thriving hub for international clinical research, was suddenly forced to adapt to unprecedented challenges. From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, she paints a vivid picture of resilience and resourcefulness under pressure. Together, Sylvain and Anna discuss the rapid regulatory adaptations that allowed continuity of care, the growing demand for clinical trial participation among internally displaced persons, and the remarkable story of a young patient whose treatment continued thanks to cross-border collaboration. Tune in to hear how clinical trials in Ukraine have not only survived but are resurging, and why patient trust, unity, and human-centered approaches are shaping the future of research in the region.

The impact of geopolitics in clinical trial location with Scott Schliebner

24 min Video

In this episode, Sylvain Berthelot welcomes Scott Schliebner, Global Head of Drug Development Consulting at Novotech. With over 25 years of experience across CRO leadership roles, Scott brings a unique perspective on how global politics and shifting market dynamics are influencing where – and how – clinical trials are run. Together, Sylvain and Scott explore the growing uncertainty created by political change, regulatory shifts, and economic pressures, and how these factors are shaping sponsor strategies. From the rise of early-phase studies in Australia and New Zealand, to the diversification of phase III trial geographies, they discuss why sponsors are increasingly reluctant to rely on a U.S.-only model. Scott explains how geopolitical factors such as trade tensions, FDA staffing challenges, and evolving diversity guidance impact trial planning, and why sponsors must think proactively about data representativeness across regions. The conversation also highlights the scientific – rather than political – benefits of conducting multi-regional trials, ensuring that new medicines reach the patients who need them most. Tune in to discover how sponsors are mitigating risk, balancing timelines and costs, and navigating the new realities of trial globalization.

Striking the right balance between risk and innovation with Marek Wasiluk

30 min Video

Sylvain Berthelot welcomes Dr. Marek Wasiluk, CEO of ClinMark. With a career that spans from CRA to leading a global CRO, Marek brings a unique perspective on how clinical research organizations can embrace innovation while safeguarding trial quality. Together, they explore the fine balance between adopting new technologies and managing operational risk. Marek shares how his background in medicine, quality assurance, and clinical operations shapes his approach to implementing digital solutions that not only meet regulatory expectations but also bring real value to sponsors and patients. Sylvain and Marek discuss why CROs must be both cautious and bold when evaluating new tools, how to build trust with clients while innovating, and the importance of curiosity and adaptability in driving meaningful change. Tune in to hear how CROs can move beyond “shiny new objects” and take a thoughtful, balanced approach to innovation in clinical trials.

Leveraging eSource in clinical data collection with Mats Sundgren

29 min Video

Join Sylvain Berthelot as he welcomes Mats Sundgren, Senior Advisor at the European Institute for Innovation through Health Data. A pioneer in implementing eSource during his years at AstraZeneca, Mats shares how this approach is transforming clinical research. Together, they explore what eSource really means and why reducing duplicate data entry at site level is such a game-changer. Mats highlights findings from a recent study with Memorial Sloan Kettering Cancer Center, which revealed the heavy time burden manual data entry places on coordinators, and how eSource can dramatically improve efficiency and data quality. The discussion also covers the promise and challenges of scaling eSource adoption: from interoperability standards like HL7 FHIR, to dealing with unstructured data using natural language processing. Mats emphasizes the role of AI as an assistant rather than a replacement, and why true progress requires aligning value across sponsors, hospitals, vendors, and regulators. Tune in to learn more about eSource, the cultural shifts needed for sustainable adoption, and the guiding principles Mats applies – rooted in Nash equilibrium.

Going paper-free in early phase trials with Joe Erato

26 min Video

Sylvain Berthelot sits down with Joe Erato, Chief Operations Officer at Spaulding Clinical. Together, they explore what it really takes to run early phase studies without paper – and why the transition to fully electronic systems can be both challenging and transformative. Joe shares how Spaulding Clinical was founded with a vision to “take clinical research into the next generation using technology,” and what it meant to implement paper-free processes from the very beginning. He reflects on the steep learning curve, the risks of being first to adopt, and the operational upheaval required to shift an entire unit away from legacy methods. Sylvain and Joe discuss the importance of integration to reduce manual entry, how real-time data capture accelerates decision-making and improves quality, and why designing systems around the patient experience is critical to compliance and study success. Tune in to hear how Spaulding Clinical built its operations from the ground up, the lessons learned along the way, and what going truly paper-free means for the future of clinical trials.

Making data surveillance a reality with Tanya Du Plessis

29 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Tanya Du Plessis, Chief Data Strategist and Solutions Officer at Bioforum. Together, they unpack what data surveillance really means and how to make it a practical reality in today’s clinical trials. With over two decades of experience in clinical data management, Tanya shares how the evolving regulatory landscape – including ICH E8 and ICH E6(R3) –  is pushing sponsors to adopt a more holistic, risk-based view of data. Rather than reacting to problems at the end of a study, she explains how data surveillance empowers teams to identify risks earlier, address root causes, and protect trial integrity. Sylvain and Tanya discuss why regulators intentionally avoid a rigid definition of data surveillance, how cross-functional collaboration between statisticians, medics, and data managers is key, and why proactive strategies ultimately save both time and cost.  Tune in to explore how data surveillance is reshaping the role of data managers, the culture of oversight, and the future of trial success.

Applying real world evidence to clinical trials with Cristina Chang

26 min Video

Applying real world evidence to clinical trials with Cristina Chang In the final episode of season 1, Sylvain Berthelot welcomes Dr. Cristina Chang, Chief Medical Officer at HiRO, to unpack the growing importance of real-world evidence (RWE) in clinical development. With decades of experience across global pharmaceutical companies, Cristina shares her deep insights into how real-world data is being applied to clinical trials to enhance patient outcomes, regulatory submissions, and post-marketing strategies. She discusses the practical considerations for using RWE, from data collection challenges to ensuring scientific rigor, as well as how the regulatory landscape is evolving to support these efforts. Cristina also reflects on cultural and organizational changes needed to integrate RWE into clinical development successfully, and how emerging technologies and cross-functional collaboration can drive this transformation. Join us as we explore how real-world evidence is shifting from a buzzword to a critical component of evidence generation in modern clinical research.

Realising the true benefits of risk management with Brian Barnes

22 min Video

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Brian Barnes, Director of Risk Management Strategy at BioNTech, to explore the human and strategic dimensions of risk-based quality management (RBQM). Drawing from his rich experience across CROs, technology vendors, and now a sponsor organisation, Brian shares how his role as a “risk assessment facilitator” reflects a broader cultural shift: developing a company-wide risk-focused mindset and moving risk management upstream into study design and operational planning. Sylvain and Brian talk about building risk frameworks from the ground up, demonstrating return on investment for RBQM and confronting resistance and misconceptions. Brian offers practical insight into why RBQM is less about the tools and more about people, collaboration, and culture. Tune in to discover what “good” risk management looks like and how to make it stick –across teams, trials, and organisations.

A new way of defining clinical endpoints with Sebastien Coppe

27 min Video

Join host Sylvain Berthelot and Sébastien Coppe, CEO and co-founder of One2Treat, to explore a patient-focused approach to redefining clinical endpoints. Drawing from his background in optimizing clinical supply chains and his passion for involving patients more deeply in trial design, Sébastien shares how One2Treat is using technology to bring the patient’s voice into the earliest stages of clinical development. The discussion touches on the limitations of traditional endpoints, the value of co-designing studies with patients, and the promise of tools that capture lived experiences to define outcomes that truly matter. Sébastien emphasizes the need to rethink how we measure success in trials, through real-world impact and patient relevance. Tune in to discover how new statistical approaches are enabling a more meaningful way to define what good looks like in clinical research.

The future of technology and AI in clinical trials with Joe Dustin

26 min Video

In this episode of Clinical Data Talks, host Sylvain Berthelot welcomes industry veteran Joe Dustin to explore the evolving landscape of eClinical technology and the impact of AI in clinical trials. With decades of experience across eClinical vendors and the sponsor side, Joe shares his insights into the major transformations shaping the industry - from paper-based processes to electronic data capture, on-premise systems to cloud platforms, and now, the rise of AI-driven solutions. Together, they discuss the current challenges of interoperability and fragmentation in clinical data, the potential of AI to enhance data management and trial design, and how standardization efforts like the USDM (Unified Study Definitions Model) are paving the way for faster and more efficient studies. This conversation is packed with valuable perspectives on where clinical technology is heading.   Clinical Data Talks is a podcast brought to you by CRScube, a leader in eClinical technology solutions.

The evolving role of data managers with Kelly Forester

24 min Video

The evolving role of data managers with Kelly Forester Sylvain Berthelot sits down with Kelly Forester, a clinical data management expert with 30 years’ experience. Kelly shares personal stories from her journey in clinical research, including how she transitioned from early roles in data entry to leading global data strategies. They both reflect on the shifting expectations for data managers, from scripted technical execution to strategic thinking. In an increasingly digital and decentralized clinical trial landscape, they discuss the need for adaptability as ever evolving technologies reshape the industry. The conversation also dives into career development, mentorship, and the growing importance of soft skills and cross-functional collaboration. Tune in to discover how data managers are not just keeping pace with change but driving it.   Clinical Data Talks is a podcast brought to you by CRScube, a leader in eClinical technology solutions.

The challenges and promises of the clinical data lifecycle with Doug Bain

31 min Video

For the first episode of Clinical Data Talks, host Sylvain Berthelot welcomes industry expert Doug Bain to explore the intricate journey of clinical data - from its initial collection to final submission. With a background spanning software development and leadership roles at eClinical vendors and CRO, Doug brings a wealth of experience and sharp industry insights. Together, they discuss the evolving challenges of managing clinical data efficiently, the impact of new technologies on data workflows, and the importance of standardization in the world of clinical data. Doug also shares his perspective on how the industry can address persistent issues like data fragmentation and interoperability while embracing innovations that enhance data integrity and usability. Tune in to learn more about the clinical data life cycle and what’s shaping its future.   Clinical Data Talks is a podcast brought to you by CRScube, a leader in eClinical technology solutions. 

–

0 ratings from members

5
4
3
2
1

Rate this podcast

Log in to rate and review the shows you listen to.

No reviews yet — be the first member to rate "Clinical Data Talks".

This podcast, its content and its artwork are not owned by, affiliated with, or endorsed by Castquire.

Keep listening

Discover more podcasts like this.

Up next

  1. Nothing queued. Use + Queue on any episode to line it up.

0:00 0:00